HiFiBiO

HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody dru... Read more

Industries

Headquarters

Cambridge, United States

Stage

Series D

Employees

51-200

Links

Org chart

Liang Schweizer

Founder, Chairperson & CEO

Collapse

COO

Interim Chief Medical Officer

Francisco Adrian

Chief Scientific Officer

General Counsel

SVP & Global Head, Business Development & Operations

Managing Director, France

Executive Director, Asia-Pacific External Innovation

Executive Director & Global Head, CMC

Senior Director, Staff & Strategy

Senior Director, External Innovation

Senior Director, Discovery Biology & In Vivo Pharmacology

Financial Controller

Director of China External Innovation

Teams

View all

Leadership Team

16 members

Board of Directors

9 members

CEO and Executive Team

6 members

Founding Team

6 members

Discover similar companies

Voyager Therapeutics

Cambridge, United States · Post IPO Equity

Exicure

Skokie, United States · Post IPO Equity

AllStripes

San Francisco, United States · Series B

Mission Bio

San Francisco, United States · Series C

Korro Bio

Cambridge, United States · Series B

Sutro Biopharma

South San Francisco, United States · Post IPO Equity

Illumina

San Diego, United States

MassBio

Cambridge, United States

CytomX

South San Francisco, United States

Axsome Therapeutics

New York, United States · Post IPO Equity

Cerus

Concord, United States · Post IPO Equity

Verge Genomics

South San Francisco, United States · Series B

Two candidates

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.